ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Neil K. Worrall
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Worrall, N. K.
Right arrow Articles by Ferguson, T. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Worrall, N. K.
Right arrow Articles by Ferguson, T. B., Jr
Related Collections
Right arrowRelated Article

Ann Thorac Surg 1996;62:378-385
© 1996 The Society of Thoracic Surgeons

Original Articles: Cardiovascular

Inhibition of Inducible Nitric Oxide Synthase Attenuates Established Acute Cardiac Allograft Rejection

Neil K. Worrall, MD, Thomas P. Misko, PhD, Patrick M. Sullivan, MA, Jia-J. Hui, MD, T. Bruce Ferguson, Jr, MD

Division of Cardiothoracic Surgery, Department of Surgery, Washington University School of Medicine and Departments of bMolecular Pharmacology and cMolecular and Cellular Biology, Searle Research and Development, Monsanto Company, St. Louis, Missouri

Background. We previously demonstrated that continuous treatment with aminoguanidine, a selective inhibitor of nitric oxide production by inducible nitric oxide synthase, attenuated acute cardiac allograft rejection.

Methods. A rat transplant model was used to determine (1) when inducible nitric oxide synthase was expressed in the allograft heart during unmodified acute rejection and (2) whether pulse therapy with aminoguanidine attenuated the histologic changes of established acute rejection, in comparison with the effects of pulse therapy with corticosteroids.

Results. Inducible nitric oxide synthase messenger RNA and protein were expressed during early and late acute rejection. Pulse therapy with aminoguanidine inhibited nitric oxide production and attenuated the histologic changes of acute rejection, but not as effectively as corticosteroid therapy (rejection scores of 4.1 ± 0.4, 2.5 ± 0.9, and 1.4 ± 0.6 on postoperative day 8, for untreated, aminoguanidine-, and dexamethasone-treated allografts, respectively (scale, 0 to 5; p < 0.05).

Conclusions. (1) Inducible nitric oxide synthase expression first occurs during early acute allograft rejection and persists throughout rejection and (2) nitric oxide is an important effector molecule in acute rejection. Inducible nitric oxide synthase inhibition may offer a therapeutic adjunct in the management of acute rejection.


Related Article

Discussion
Ann. Thorac. Surg. 1996 62: 385. [Extract] [Full Text]



This article has been cited by other articles:


Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
G. M. Pieper, V. Nilakantan, G. Hilton, X. Zhou, A. K. Khanna, N. L. N. Halligan, C. C. Felix, B. Kampalath, O. W. Griffith, M. A. Hayward, et al.
Variable efficacy of N6-(1-iminoethyl)-L-lysine in acute cardiac transplant rejection
Am J Physiol Heart Circ Physiol, February 1, 2004; 286(2): H525 - H534.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
G. M. Pieper, V. Nilakantan, G. Hilton, N. L. N. Halligan, C. C. Felix, B. Kampalath, A. K. Khanna, A. M. Roza, C. P. Johnson, and M. B. Adams
Mechanisms of the protective action of diethyldithiocarbamate-iron complex on acute cardiac allograft rejection
Am J Physiol Heart Circ Physiol, May 1, 2003; 284(5): H1542 - H1551.
[Abstract] [Full Text] [PDF]

Home page
 Exp. Biol. Med.Home page
E. Akizuki, T. Akaike, S. Okamoto, S. Fujii, Y. Yamaguchi, M. Ogawa, and H. Maeda
Role of Nitric Oxide and Superoxide in Acute Cardiac Allograft Rejection in Rats
Experimental Biology and Medicine, November 1, 2000; 225(2): 151 - 159.
[Abstract] [Full Text]

Home page
 CirculationHome page
X. Yang, N. Ma, M. J. Szabolcs, J. Zhong, E. Athan, R. R. Sciacca, R. E. Michler, G. D. Anderson, J. F. Wiese, K. M. Leahy, et al.
Upregulation of COX-2 During Cardiac Allograft Rejection
Circulation, February 1, 2000; 101(4): 430 - 438.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
P. J. Cannon, X. Yang, M. J. Szabolcs, S. Ravalli, R. R. Sciacca, and R. E. Michler
The role of inducible nitric oxide synthase in cardiac allograft rejection
Cardiovasc Res, April 1, 1998; 38(1): 6 - 15.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1996 by The Society of Thoracic Surgeons.